---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-002237"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2025-01-15T23:59:59+00:00"
generated_at: "2026-05-28T01:21:58.215636+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Ocean Biomedical receives Nasdaq delisting notice for failure to hold annual meeting

## Summary
- Nasdaq notified Ocean Biomedical on Jan 7, 2025, that it failed to hold an annual meeting within 12 months of FY2023 end, violating Rule 5620(a).
- This deficiency serves as an additional basis for delisting; the Nasdaq Hearings Panel will consider it in the ongoing listing review.
- Company must submit views by Jan 14, 2025, and plans to hold annual meeting no later than March 31, 2025.

## SEC filing metadata
- accession: 0001493152-25-002237
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2025-01-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000149315225002237/0001493152-25-002237-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000149315225002237/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-002237
- JSON: https://secwatch.observer/filing/0001493152-25-002237.json
- Plain text: https://secwatch.observer/filing/0001493152-25-002237.txt

## Source-grounded claims
- claim_id: 90aa6e9e404ffcde6f85b8624e4e25ad96cea62e
  claim: Ocean Biomedical, Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a), 5810(c)(2)(G)).
  evidence_excerpt: January 7, 2025, the Company received a notice from Nasdaq that since the Company had not yet held an annual meeting of shareholders within twelve months of the Company’s fiscal year ended December 31, 2023, it no longer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1869974/000149315225002237/0001493152-25-002237-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.